ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Two lots of Kogenate® recalled due to mislabelling
July 25, 2019Two lots of Kogenate® FS vials actually contain the FVIII hemophilia A treatment, Jivi®. -
Bayer's Jivi approved in Europe for previously treated haemophilia A
November 29, 2018Bayer has revealed that its recombinant Factor VIII (rFVIII) replacement therapy Jivi, also known as BAY94-9027, has received approval from the European Commission for the treatment... -
EU gives Bayer's Jivi the green light
Jivi (formerly BAY94-9027) has been approved by the European Commission for the treatment and prophylaxis of bleeding in previously treated patients 12 years of age or older...
-
Bayer Inc. receives approval for hemophilia A treatment Jivi
October 25, 2018Bayer Inc. receives approval for hemophilia A treatment Jivi -
Bayer wins US nod for Jivi
September 14, 2018US regulators have approved Bayer’s Jivi (formerly BAY94-9027), a longer-acting Factor VIII therapy designed to reduce the number of infusions... -
Bayer Receives FDA Approval for Jivi
August 31, 2018Bayer announced the U.S. Food and Drug Administration (FDA) has approved Jivi (BAY94-9027, antihemophilic factor [recombinant] PEGylated-aucl) for the routine prophylactic treatment of hemophilia A in previously treated adults and adolescents 12 years of
Pharma Sources Insight January 2025
